in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharmaceuticals and Return on Investment (ROI)
4:23 AM MDT | March 27, 2009 | Girish Malhotra
Every reader is an investor. Investors know that there has to be a good return on their investment irrespective of the place of investment. We have all been taught that different risks necessitate different ROI. For “low risk investments,” ROI of 10-24% is suggested, 24% being in Pharmaceuticals. The ROI range for “average risk” is about 15-40%. Again, 40% is for pharmaceuticals. ROI for high-risk investments should be 24-56% with 56% for Pharmaceuticals (1). In the past few weeks, three major pharmaceutical mergers...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee